Literature DB >> 26920592

Coronary atherosclerosis in outlier subjects at the opposite extremes of traditional risk factors: Rationale and preliminary results of the Coronary Atherosclerosis in outlier subjects: Protective and novel Individual Risk factors Evaluation (CAPIRE) study.

Marco Magnoni1, Daniele Andreini2, Marco Gorini3, Tiziano Moccetti4, Maria Grazia Modena5, Mauro Canestrari6, Sergio Berti7, Giancarlo Casolo8, Domenico Gabrielli9, Paolo Marraccini10, Gianluca Pontone2, Serge Masson11, Roberto Latini11, Aldo Pietro Maggioni3, Attilio Maseri12.   

Abstract

Although it is generally accepted that cardiac ischemic events develop when coronary atherosclerosis (coronary artery disease [CAD]) has reached a critical threshold, this is true only to a first approximation. Indeed, there are patients with severe CAD who do not develop ischemic events; conversely, at the other extreme, individuals with minimal CAD may do. Similar exceptions to this paradigm include patients with diffuse CAD with a low risk factor (RF) profile and others with multiple RFs who develop only mild or no CAD. Therefore, the CAPIRE project was designed to investigate whether the specific study of these extreme outlier populations could provide clues for identification of yet unknown risk or protective factors for CAD and ischemic events. In the CAPIRE study, 481 subjects without previous symptoms or history of ischemic heart disease and normal left ventricular systolic function undergoing coronary computed tomography angiography have been selected based on coronary computed tomography angiography findings and cardiovascular RF profile. Therefore, in the whole population, 2 extreme outlier populations have been identified: (1) subjects with no CAD despite multiple RFs, and (2) at the opposite extreme, subjects with diffuse CAD despite a low-risk profile. Each subject has been characterized by clinical, anatomical imaging variables of CAD and baseline circulating biomarkers. Blood samples were collected and stored in a biological bank for further advanced investigations. The project is designed as a prospective, observational, international multicenter study with an initial cross-sectional analysis of clinical, imaging, and biomolecular variables in the selected groups and a longitudinal 5-year follow-up.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26920592     DOI: 10.1016/j.ahj.2015.11.017

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans.

Authors:  Ele Ferrannini; Maria Laura Manca; Giulia Ferrannini; Felicita Andreotti; Daniele Andreini; Roberto Latini; Marco Magnoni; Stephen A Williams; Attilio Maseri; Aldo P Maggioni
Journal:  Front Cardiovasc Med       Date:  2022-02-04

2.  Osteopontin as Candidate Biomarker of Coronary Disease despite Low Cardiovascular Risk: Insights from CAPIRE Study.

Authors:  Federico Carbone; Jennifer Meessen; Marco Magnoni; Daniele Andreini; Aldo Pietro Maggioni; Roberto Latini; Fabrizio Montecucco
Journal:  Cells       Date:  2022-02-15       Impact factor: 6.600

3.  Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE Study.

Authors:  Martino Deidda; Antonio Noto; Christian Cadeddu Dessalvi; Daniele Andreini; Felicita Andreotti; Eleuterio Ferrannini; Roberto Latini; Aldo P Maggioni; Marco Magnoni; Giuseppe Mercuro
Journal:  Metabolites       Date:  2022-01-27

4.  Predictive value of HDL function in patients with coronary artery disease: relationship with coronary plaque characteristics and clinical events.

Authors:  Marco Magnoni; Daniele Andreini; Angela Pirillo; Patrizia Uboldi; Roberto Latini; Alberico L Catapano; Aldo P Maggioni; Giuseppe D Norata
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

5.  Metabolic profiling reveals the heterogeneity of vascular endothelial function phenotypes in individuals at extreme cardiovascular risk.

Authors:  Baoyu Mao; Yanshan Yi; Qiuyan Mo; Chunxiu Yang; Qiuan Zhong
Journal:  RSC Adv       Date:  2019-09-23       Impact factor: 4.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.